1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pineal parenchymal tumor of intermediate differentiation (PPTID) is a neoplasm of pinealocyte origin and of intermediate differentiation (WHO grade 2 or 3). Treatment selection and prognostication is challenging for this rare, recently characterized tumor. In this single study, we review our clinical experience in patients with PPTID as well as pooled data from two other institutions.

          Related collections

          Author and article information

          Journal
          J Neurooncol
          Journal of neuro-oncology
          Springer Science and Business Media LLC
          1573-7373
          0167-594X
          Nov 2022
          : 160
          : 2
          Affiliations
          [1 ] Department of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA. webb.mason@mayo.edu.
          [2 ] Department of Radiology, Mayo Clinic, Rochester, MN, USA.
          [3 ] Department of Neurology, Mayo Clinic, Rochester, MN, USA.
          [4 ] Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
          [5 ] Department of Oncology, Mayo Clinic, Rochester, MN, USA.
          Article
          10.1007/s11060-022-04174-6
          10.1007/s11060-022-04174-6
          36301435
          3977e47b-b11d-4bac-a177-6d5c69892056
          History

          Pineal,Radiation therapy,Outcome,Parenchymal tumor of intermediate differentiation (PPTID),Primary CNS tumors

          Comments

          Comment on this article